Qube Research & Technologies Ltd - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 170 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1,096,833
-41.7%
39,061
-53.9%
0.01%
-57.1%
Q2 2022$1,880,000
+82.2%
84,801
+139.1%
0.01%
+55.6%
Q1 2022$1,032,000
-8.3%
35,466
+3.6%
0.01%0.0%
Q4 2021$1,126,000
+85.2%
34,241
+97.0%
0.01%0.0%
Q3 2020$608,000
+31.6%
17,385
+33.6%
0.01%
-52.6%
Q1 2020$462,00013,0090.02%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 3,057,869$86,477,0002.23%
Eagle Health Investments LP 329,713$9,324,0002.14%
Bellevue Group AG 4,058,792$114,783,0001.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 959,214$27,127,0001.13%
ARMISTICE CAPITAL, LLC 1,924,000$54,411,0000.94%
Integral Health Asset Management, LLC 100,000$2,828,0000.55%
Monarch Partners Asset Management LLC 57,820$1,635,0000.49%
ArrowMark Colorado Holdings LLC 1,380,389$39,037,0000.48%
AlphaCentric Advisors LLC 15,000$424,0000.44%
PDT Partners, LLC 72,778$2,058,0000.31%
View complete list of AGIOS PHARMACEUTICALS INC shareholders